The series of the season isn’t over. One day, it’s a yes, we’ve found the miracle cure; another day, it’s a no, it’s useless!
And what if all this controversy was just a marketing technique to promote the quickly published book by Professor Eric Raoult: “Epidemics: Real Dangers, False Alarms” (Michel Lafon edition)?
This book seems to be enjoying real success.
Evil be to him who evil thinks… but if it’s not true, it’s at least highly probable.
As they say in these cases… until next time.
The officials of the British clinical trial Recovery announced in a statement the “immediate” halt of including new patients for this treatment.
Recovery, a major clinical trial whose results were eagerly awaited, was one of the few not to have suspended its tests on hydroxychloroquine after a controversial study by The Lancet, which has since been retracted, highlighted the ineffectiveness or even harmful effects of the controversial drug.
The European study Discovery, which evaluates the effectiveness of four treatments against the Covid-19 disease, plans “to resume the inclusion” of new patients receiving hydroxychloroquine, ten days after suspending them based on the study published in “The Lancet”.
